These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 19126645)

  • 21. Omega-3 polyunsaturated fatty acids regulate syndecan-1 expression in human breast cancer cells.
    Sun H; Berquin IM; Edwards IJ
    Cancer Res; 2005 May; 65(10):4442-7. PubMed ID: 15899837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of human breast cancer cell (MBA-MD-231) invasion by the Ea4-peptide of rainbow trout pro-IGF-I.
    Siri S; Chen MJ; Chen TT
    J Cell Biochem; 2006 Dec; 99(5):1363-73. PubMed ID: 16795042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting of syndecan-1 by microRNA miR-10b promotes breast cancer cell motility and invasiveness via a Rho-GTPase- and E-cadherin-dependent mechanism.
    Ibrahim SA; Yip GW; Stock C; Pan JW; Neubauer C; Poeter M; Pupjalis D; Koo CY; Kelsch R; Schüle R; Rescher U; Kiesel L; Götte M
    Int J Cancer; 2012 Sep; 131(6):E884-96. PubMed ID: 22573479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
    Xue A; Xue M; Jackson C; Smith RC
    Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth.
    Zhao YH; Zhou M; Liu H; Ding Y; Khong HT; Yu D; Fodstad O; Tan M
    Oncogene; 2009 Oct; 28(42):3689-701. PubMed ID: 19668225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
    Li XF; Yan PJ; Shao ZM
    Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cells.
    Robertson FM; Simeone AM; Mazumdar A; Shah AH; McMurray JS; Ghosh S; Cristofanilli M
    J Exp Ther Oncol; 2008; 7(4):299-312. PubMed ID: 19227010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Programmed cell death 4 inhibits leptin-induced breast cancer cell invasion.
    González-Villasana V; Nieves-Alicea R; McMurtry V; Gutiérrez-Puente Y; Tari AM
    Oncol Rep; 2012 Mar; 27(3):861-6. PubMed ID: 22200873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of estrogen receptor beta increases integrin alpha1 and integrin beta1 levels and enhances adhesion of breast cancer cells.
    Lindberg K; Ström A; Lock JG; Gustafsson JA; Haldosén LA; Helguero LA
    J Cell Physiol; 2010 Jan; 222(1):156-67. PubMed ID: 19780039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Luteinizing hormone-induced up-regulation of ErbB-2 is insufficient stimulant of growth and invasion in ovarian cancer cells.
    Warrenfeltz SW; Lott SA; Palmer TM; Gray JC; Puett D
    Mol Cancer Res; 2008 Nov; 6(11):1775-85. PubMed ID: 19010824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of an aggressive MCF-7 cell line variant, TMX2-28, to study cell invasion in breast cancer.
    Gozgit JM; Pentecost BT; Marconi SA; Otis CN; Wu C; Arcaro KF
    Mol Cancer Res; 2006 Dec; 4(12):905-13. PubMed ID: 17189381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leptin-regulated gene expression in MCF-7 breast cancer cells: mechanistic insights into leptin-regulated mammary tumor growth and progression.
    Perera CN; Chin HG; Duru N; Camarillo IG
    J Endocrinol; 2008 Nov; 199(2):221-33. PubMed ID: 18715880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Signal transducers and activators of transcription-3 up-regulates tissue inhibitor of metalloproteinase-1 expression and decreases invasiveness of breast cancer.
    Dien J; Amin HM; Chiu N; Wong W; Frantz C; Chiu B; Mackey JR; Lai R
    Am J Pathol; 2006 Aug; 169(2):633-42. PubMed ID: 16877361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TrkA overexpression enhances growth and metastasis of breast cancer cells.
    Lagadec C; Meignan S; Adriaenssens E; Foveau B; Vanhecke E; Romon R; Toillon RA; Oxombre B; Hondermarck H; Le Bourhis X
    Oncogene; 2009 May; 28(18):1960-70. PubMed ID: 19330021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Fra-2 in breast cancer: influence on tumor cell invasion and motility.
    Milde-Langosch K; Janke S; Wagner I; Schröder C; Streichert T; Bamberger AM; Jänicke F; Löning T
    Breast Cancer Res Treat; 2008 Feb; 107(3):337-47. PubMed ID: 17393299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ezrin silencing by small hairpin RNA reverses metastatic behaviors of human breast cancer cells.
    Li Q; Wu M; Wang H; Xu G; Zhu T; Zhang Y; Liu P; Song A; Gang C; Han Z; Zhou J; Meng L; Lu Y; Wang S; Ma D
    Cancer Lett; 2008 Mar; 261(1):55-63. PubMed ID: 18155831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression.
    Zhang Y; Yao F; Yao X; Yi C; Tan C; Wei L; Sun S
    Oncol Rep; 2009 Apr; 21(4):1113-21. PubMed ID: 19288016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of intraperitoneal tumor growth of human ovarian cancer cells by bi- and trifunctional inhibitors of tumor-associated proteolytic systems.
    Krol J; Kopitz C; Kirschenhofer A; Schmitt M; Magdolen U; Krüger A; Magdolen V
    Biol Chem; 2003 Jul; 384(7):1097-102. PubMed ID: 12956426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucose-regulated protein 78 as a novel effector of BRCA1 for inhibiting stress-induced apoptosis.
    Yeung BH; Kwan BW; He QY; Lee AS; Liu J; Wong AS
    Oncogene; 2008 Dec; 27(53):6782-9. PubMed ID: 18776923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.
    Liu S; Goldstein RH; Scepansky EM; Rosenblatt M
    Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.